v3.26.1
Shareholders’ Equity (Tables)
 6 Months Ended
Jun. 30, 2026
Shareholders’ Equity [Abstract]  
Schedule of Share Option Plan

A summary of the status of options under the Plan as of June 30, 2026 and changes during the relevant period ended on that date is presented below:

 

    Six months ended
June 30, 2026 (unaudited)		  
    Number of
options		     Weighted
average
exercise
price		     Aggregate
intrinsic
value		     Weighted
average
remaining
contractual life
(years)		  
Outstanding at beginning of period     16,746,951     $ 4.41     $ 22,630       6.46  
Granted     1,471,035     $ 6.65                  
Exercised     (902,512 )   $ 3.20                  
Forfeited     (411,739 )   $ 4.51                  
                                 
Outstanding at end of period     16,903,735     $ 4.67     $ 133,756       6.53  
                                 
Exercisable options     12,943,952     $ 4.81     $ 100,547       5.88  
Schedule of RSUs Under the Plan

A summary of the status of RSUs under the Plan as of June 30, 2026 and changes during the relevant period ended on that date is presented below:

 

    Number of
RSUs		     Weighted-
average
grant date
fair value
per share		  
Unvested at December 31, 2025     747,506     $ 3.16  
Granted     419,953     $ 5.29  
Vested     (309,565 )   $ 4.41  
Forfeited     (47,729 )   $ 3.05  
                 
Unvested at June 30, 2026     810,165     $ 3.79  
Schedule of Total Equity-Based Compensation Expense

The total equity-based compensation expense related to all of the Company’s equity-based awards recognized for the six months ended June 30, 2025 and 2026, was comprised as follows:

 

    Six months ended
June 30,		  
    2025     2026  
    Unaudited  
Research and development   $ 3,194     $ 4,304  
Marketing expenses     427       65  
General and administrative     1,710       2,331  
                 
Total share-based compensation expense   $ 5,331     $ 6,700